Noxopharm Ltd
OTC:NOXOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Noxopharm Ltd
OTC:NOXOF
|
AU |
|
Air Canada
TSX:AC
|
CA |
|
Grupo Aeroportuario del Pacifico SAB de CV
OTC:GPAEF
|
MX |
|
T
|
Thales SA
LSE:0IW5
|
FR |
|
H
|
H2O Innovation Inc
PAR:ALHEO
|
CA |
|
G
|
Gartner Inc
LSE:0ITV
|
US |
|
D
|
Deoleo SA
SWB:SC5A
|
ES |
|
S
|
Saipem SpA
F:SPEA
|
IT |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
N
|
NiSource Inc
F:NOU
|
US |
|
P
|
Phillips 66
F:R66
|
US |
|
WP Carey Inc
NYSE:WPC
|
US |
|
A
|
Ability Inc
TASE:ABIL
|
IL |
Bankruptcy Probability
Noxopharm Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Noxopharm Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Noxopharm Ltd
ASX:NOX
|
17.5m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Noxopharm Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Noxopharm Ltd has total debt of 4.2m AUD. This includes both short-term (4.2m AUD) and long-term (0 AUD) debt.
You can find a full breakdown on its Balance Sheet.
